Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Topharman
Anqiu, Shandong, China
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
Topharman is a leading Chinese CMO/CDMO and API manufacturer, exporting commercial quantities of APIs with regulatory files (e.g., DMF, CEP, JDMF) for global regulated markets, including the US, EU, Japan, and more. Its technology for synthesis of several APIs is noted as internationally competitive and used by other pharma manufacturers[1][2][9].
- Therapeutic areas
- PsychiatryMen's HealthInfectious DiseasesCardiovascularOtherOncology
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
Beyond the preview
Go deeper on Topharman.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Topharman.